Position in AMGN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$187,050,551
+$1,071,790 QoQ
Shares Held
516,543
-2.3% QoQ
Ownership
0.096%
of shares outstanding
% of Portfolio
0.49%
of 13F equity value
Holder Rank
#92
of 3,149 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 72%
Shared 0%
None 28%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CAPTRUST FINANCIAL ADVISORS holds $1,882,423,234 across 16 Drug Manufacturers - General names. AMGN ranks #6 (9.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
1,817,391 | $457,328,271 | |
| 2 | LLY |
ELI LILLY & Co
|
308,951 | $370,565,128 | |
| 3 | MRK |
Merck & Co., Inc.
|
2,054,383 | $263,988,215 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
1,763,525 | $222,803,748 | |
| 5 | JNJ |
Johnson & Johnson
|
783,288 | $198,931,653 | |
| 6 | AMGN |
Amgen Inc
This page
|
516,543 | $187,050,551 | |
| 7 | PFE |
Pfizer Inc
|
3,628,237 | $87,367,946 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
607,026 | $34,976,838 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $187,050,551 | 516,543 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $185,978,761 | 528,574 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $163,087,117 | 498,265 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $137,065,386 | 485,703 | Shares | Sole | 2025-11-19 | |
| 2025-06-30 | $128,009,408 | 458,470 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $141,629,695 | 454,597 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $154,918,942 | 594,379 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $188,050,133 | 583,626 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $177,900,593 | 569,373 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $183,535,099 | 645,523 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $116,459,158 | 404,344 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $107,648,861 | 400,539 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $88,633,492 | 399,214 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $93,905,128 | 388,439 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $102,056,125 | 388,578 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $87,347,909 | 387,524 | Shares | Sole | 2022-11-16 | |
| 2022-06-30 | $82,216,665 | 337,923 | Shares | Sole | 2022-08-23 | |
| 2022-03-31 | $74,969,278 | 310,021 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $66,933,974 | 297,524 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $72,563,410 | 341,234 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $77,660,700 | 318,608 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $72,931,436 | 293,121 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $62,566,290 | 272,122 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $63,337,688 | 249,204 | Shares | Sole | 2020-11-17 | |
| 2020-06-30 | $56,057,789 | 237,674 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $43,310,426 | 213,636 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||